Recro Pharma

-$0.04 (-1.70%) As of 7:17 PM UTC today

Why Robinhood?

You can buy or sell Recro Pharma and other stocks, options, and ETFs commission-free!

About REPH

Recro Pharma, Inc. Common Stock, also called Recro Pharma, is a pharmaceutical company, which engages in the contract development and manufacturing organization (CDMO).

CEO
J. David Enloe
Employees
185
Headquarters
Exton, Pennsylvania
Founded
2007

REPH Key Statistics

Market Cap
101.85M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
731.60K
High Today
$2.07
Low Today
$1.98
Open Price
$2.03
Volume
555.41K
52 Week High
$5.29
52 Week Low
$1.49

REPH Earnings

-$0.48
-$0.32
-$0.16
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure